Approximations of the target-mediated drug disposition model and identifiability of model parameters
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology
Link
http://link.springer.com/content/pdf/10.1007/s10928-008-9102-8.pdf
Reference6 articles.
1. Mager DE, Jusko WJ (2001) General pharmacokinetic model for drugs exhibiting target-mediated drug disposition. J Pharmacokinet Pharmacodyn 28: 507–532. doi: 10.1023/A:1014414520282
2. Mager DE, Krzyzanski W (2005) Quasi-equilibrium pharmacokinetic model for drugs exhibiting target-mediated drug disposition. Pharm Res 22(10): 1589–1596. doi: 10.1007/s11095-005-6650-0
3. Segel IH (1975) Enzyme kinetics. Behavior and analysis of rapid equilibrium and steady-state enzyme systems. Wiley, New York
4. Hayashi N, Tsukamoto Y, Sallas WM, Lowe PJ (2007) A mechanism-based binding model for the population pharmacokinetics and pharmacodynamics of omalizumab. Br J Clin Pharmacol 63(5): 548–561. doi: 10.1111/j.1365-2125.2006.02803.x
5. Beal SL, Sheiner LB, Boeckmann AJ (eds) (1989–2007) NONMEM users guides. Icon Development Solutions, Ellicott City
Cited by 221 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A model‐based approach using GSK3772847, an anti‐interleukin‐33 receptor monoclonal antibody, as a showcase to predict SC administration PK and free target dynamics based on PK and total target measurements after IV administration;CPT: Pharmacometrics & Systems Pharmacology;2024-09-11
2. General quasi-equilibrium multivalent binding model to study diverse and complex drug-receptor interactions of biologics;Journal of Pharmacokinetics and Pharmacodynamics;2024-08-17
3. Population pharmacokinetics of total and unbound valemetostat and platelet dynamics in healthy volunteers and patients with non‐Hodgkin lymphoma;CPT: Pharmacometrics & Systems Pharmacology;2024-07-30
4. An asymptotic description of a basic FcRn-regulated clearance mechanism and its implications for PBPK modelling of large antibodies;Journal of Pharmacokinetics and Pharmacodynamics;2024-06-24
5. Population pharmacokinetics of imetelstat, a first‐in‐class oligonucleotide telomerase inhibitor;CPT: Pharmacometrics & Systems Pharmacology;2024-05-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3